Zynex Inc. company and executive profile by Barron's. View the latest ZYXIQ company infomation and executive bios.

Zynex Inc. ZYXI recently announced the Food and Drug Administration (“FDA”) clearance of its new TensWave device, which aligns perfectly with Zynex’s commitment to providing comprehensive pain ...

ENGLEWOOD, Colo., Feb. 2, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...

ENGLEWOOD, Colo., Nov. 13, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...

Zynex ( ($ZYXI) ) has shared an update. On December 15, 2025, Zynex, Inc. filed for Chapter 11 bankruptcy in the Southern District of Texas, ...

ENGLEWOOD, Colo., Sept. 3, 2024 /PRNewswire/ -- Zynex Inc. (NASDAQ: ZYXI), a leading medical technology company specializing in non-invasive medical devices for pain management and rehabilitation, ...

Zynex has announced it received FDA clearance for a new device used primarily for treating female urinary incontinence, according to a news release. The InWave medical device will be manufactured, ...

The lawsuit contends that Zynex engaged in a scheme to inflate its reported revenue by routinely sending patients more products, including electrodes, than were medically necessary. This practice, the ...

Zynex Inc's (NASDAQ:ZYXI) board of directors approved a program to repurchase up to $20.0 million. The program will commence on November 1, 2023, and is scheduled to terminate earlier than November 1, ...

LONE TREE, Colo., Feb. 1, 2018 /PRNewswire/ -- Zynex, Inc. (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...